Science Explorer Back to mapMap
Discussion
Researcher · Instituto Alexander Fleming · Argentina

Claudio Martín

Claudio Martín publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, on topics such as Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Colorectal Cancer Treatments and Studies.

OpenAlex
World rank
#6,646,552
of 7,710,434 ranked researchers
Rank in Argentina
#28,438
of 38,473
Works
20
Citations
68
Citations per work
3.4
h-index
6
i10-index 3Top 84% in Oncology
Claudio Martín

What does Claudio Martín research?

Claudio Martín's work is mostly in Medicine (71%), Immunology and Microbiology (6%).

Health Sciences: 14 works · 70.5% of their workMedicine: 14 works · 70.5% of their workOncology: 5 works · 24.1% of their workPulmonary and Respiratory Medicine: 4 works · 20.4% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 13.0% of their workEpidemiology: 1 works · 7.4% of their workSurgery: 1 works · 5.6% of their workEverything else: 5 works · 23.9% of their workLife Sciences: 1 works · 5.6% of their workImmunology and Microbiology: 1 works · 5.6% of their workImmunology: 1 works · 5.6% of their workTHEIR WORKClaudio Martín20works
Life Sciences6%Health Sciences71%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1470.5%
  2. Everything else523.9%
    1. Immunology and Microbiology15.6%
  1. 1Oncology24% of their works
  2. 2Pulmonary and Respiratory Medicine20% of their works
  3. 3Radiology, Nuclear Medicine and Imaging13% of their works
  4. 4Epidemiology7% of their works
  5. 5Surgery6% of their works
  6. 6Immunology6% of their works

Research topics

Which keywords describe Claudio Martín's research?

The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, ALK Inhibitors, EGFR Mutations, Cetuximab, Immune Checkpoint Blockade and KRAS Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Chemotherapy73 topics
  2. Clinical Trials72 topics
  3. Targeted Therapy72 topics
  4. ALK Inhibitors51 topic
  5. EGFR Mutations51 topic
  6. Cetuximab31 topic
  7. Immune Checkpoint Blockade31 topic
  8. KRAS Mutations31 topic
  9. PD-1 and PD-L131 topic
  10. CT Screening21 topic
  11. Dosimetry21 topic
  12. Genomic Profiles21 topic
  13. Lung Cancer21 topic
  14. NK Cell Recognition21 topic
  15. Natural Killer Cells21 topic
  16. Neuroendocrine Tumors21 topic
  17. Pancreatic Neuroendocrine Tumors21 topic
  18. Radiotherapy Physics21 topic
  19. Small-Cell Lung Cancer21 topic

Where does Claudio Martín work?

Claudio Martín's main affiliation in the publication record is Instituto Alexander Fleming, Argentina.

How many publications and citations does Claudio Martín have?

OpenAlex counts 20 works and 68 citations for Claudio Martín, an h-index of 6, ranking #6,646,552 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Claudio Martín

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Claudio Martín. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.